SanFran,

Re-watch the most recent webcast for Zenith and also read Masila's transcript for Zenith from the June 30th meeting. I did both this week and it helped remind me of why to be excited for Zenith....timelines for trials, new molecules, new indications, possible IPO, benefits of royalties from RVX-208, etc. Probably nothing will be heard prior to the Annual Meeting, which I am assuming will be around September 30th. But re-watch the video and read the transcript and see how you feel.

As for Resverlogix, my opinion is there will be silence for the next 2 weeks as we close out August weekdays. However, starting in that last weekend of August, the presentations start. Lots of opportunity there for additional exposure and possible new announcements at scheduled events in September too. Similar to above for Zenith, I'm not expecting anything major until the September 30th Annual Meeting, but I hope to be wrong!

7 weeks and counting.